Novartis said profit will rise this year as new medicines help offset competition from copycats of its best-selling drug.

As Trump appointee and vaccine skeptic RFK Jr. looks toward Washington, Novartis (NVS) CEO Vas Narasimhan is concerned about the future of healthcare. In a recent episode of Opening Bid ...

Novartis AG’s plan to sell its 70.6% stake in Novartis India is on track, CEO Vas Narasimhan confirmed at the World Economic Forum in Davos. Speaking to CNBC-TV18, he emphasised the company’s ...

Novartis' CEO Vas Narasimhan on Tuesday, January 21, said the company remains committed to India, but it will take at least another decade before the Indian pharmaceutical market matures enough to ...

0821 GMT – U.S. president Trump’s pro-innovation stance could boost new drug discoveries, Novartis chief executive officer Vas Narasimhan tells CNBC at the World Economic Forum in Davos.

Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of years thanks to new technologies, former U.S. Treasury Secretary ...

Moves by the incoming Trump Administration may be a boon to drugmakers, Novartis AG Chief Executive Officer Vas Narasimhan said, while concerns over vaccine policies and public health funding are ...

Novartis CEO Vas Narasimhan says the pharma industry hopes ... Nazis shattered her family’s store in 1938. She just learned it’s still there. I visited the city that's been nicknamed the ...

Elsewhere, Vas Narasimhan, the CEO of Swiss drugmaker Novartis AG, said he thought worry about the Trump administration’s stances on vaccines and other health-policy matters was overblown ...

The Vanguard Australian Shares Index ETF (ASX: VAS) is typically one of the ASX exchange-traded funds (ETFs) with a leading dividend yield. An investor with $10,000 invested in the VAS ETF ...

The Vanguard Australian Shares Index ETF (ASX: VAS) is a popular investment on the ASX. How popular? Well, VAS is only the largest exchange-traded fund (ETF) on the ASX by assets under management ...

Novartis CEO Vas Narasimhan outlined projections for the company's future at the 2025 JP Morgan Healthcare conference in San Francisco on 14 January. Novartis, he said, expects peak sales of over ...